University of Liverpool £1.3M to develop new inhaled drug delivery platforms to treat viral and bacterial infections
The project aims to develop a technology that will revolutionise the treatment of respiratory infections, such as pneumococcal pneumonia and COVID-19.
Mar 09 2022